Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumors entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

M Debiec-Rychter, H Dumez, I Judson, B Wasag, Jaap Verweij, M Brown, S Dimitrijevic, R Sciot, M Stul, H Vranck, M Scurr, A Hagemeijer, M Glabbeke, AT van Oosterom

Research output: Contribution to journalArticleAcademicpeer-review

422 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)689-695
Number of pages7
JournalEuropean Journal of Cancer
Volume40
DOIs
Publication statusPublished - 2004

Research programs

  • EMC MM-03-86-08

Cite this